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Abstract
Background: X-linked retinoschisis is one of the more frequently encountered inherited macular retinal disorders
affecting young males, causing loss of vision. Patients exhibit macular schisis and peripheral schisis, which can
mimic retinal detachment, a very different entity that requires surgical intervention.
Case presentation: An 8-month-old African-American boy was presented to our hospital with severe X-linked
retinoschisis involving symmetrical bullous peripheral retinoschisis in both eyes, mimicking retinal detachment. One
eye received multiple surgeries for retinal detachment repair that were complicated by proliferative vitreoretinopathy.
Later, portable optical coherence tomography was used to confirm absence of retinal detachment despite a
corrugated fundus appearance in the fellow eye. Following treatment with topical dorzolamide 2 % for 18 months,
there was dramatic regression of both macular and peripheral schisis cavities in the nonoperative eye.
Conclusions: Severe bullous peripheral schisis in infants with severe X-linked retinoschisis may produce posterior
corrugations that mimic rhegmatogenous retinal detachment. Clinical suspicion for retinal detachment in infants
with X-linked retinoschisis should be confirmed by portable optical coherence tomography before surgical
intervention. Bullous peripheral schisis can remain clinically stable over time, but topical dorzolamide 2 % may
facilitate collapse.
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Background
X-linked retinoschisis (XLRS), caused by a mutation in
the retinoschisin gene (RS1) [1], has been reported
among multiple ethnicities and has an estimated preva-
lence of between 1 in 15,000 and 1 in 30,000 people [2].
Almost all patients exhibit macular schisis, and half have
peripheral schisis. Optical coherence tomography (OCT)
demonstrates that macular schisis involves all retinal
layers, while extramacular schisis occurs near the nerve
fiber layer [1, 3]. Persistence of macular schisis eventu-
ally degrades into macular atrophy and permanent loss
of vision. Peripheral involvement can be complicated by
vitreous hemorrhage and retinal detachment (RD). Schi-
sis can be severe, mimicking RD; however, treatment for
these two entities is very different.
Carbonic anhydrase inhibitors (CAIs) have been used
for treatment of macular schisis of various causes [3].
CAIs function by acidifying the subretinal space, increas-
ing fluid transport across the retinal pigment epithelium.
Although CAIs have been reported to reduce mild mid-
peripheral schisis to a degree measurable by OCT [4],
we present a case of a patient with XLRS, which was
thought to be RD on initial examination, who had a dra-
matic response of both macular and severe peripheral
schisis to topical dorzolamide 2 %.
Case presentation
An 8-month-old otherwise healthy African-American boy
was presented to our hospital with poor visual behavior.
His past medical history was unremarkable, and he had no
contributory toxic or medication exposures. His visual
acuity at presentation was measured as centered, steady
but unmaintained in both eyes, and with a negative in-
duced tropia test. His pupillary responses were sluggish,
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but he had no afferent pupillary defect. His examination
showed very bullous anterior retinal elevations, posterior
retinal corrugations, and cystic foveae that appeared to rep-
resent severe XLRS with bilateral chronic rhegmatogenous
RDs and macular holes (MHs) (Fig. 1). Genetic testing
revealed a hemizygous R197H mutation in the RS1 gene.
The patient underwent unsuccessful schisis drainage
externally, followed by vitrectomy for RD repair. The
repair was complicated by multiple recurrences of RD
from proliferative vitreoretinopathy (PVR) that ultim-
ately resolved following extensive retinectomy and sili-
cone oil tamponade. The patient’s right eye (Fig. 2a)
was started on dorzolamide 2 % twice per day. Follow-
ing 18 months of therapy, a dramatic regression of
both macular and peripheral schisis cavities with re-
sidual intraschisis hemorrhage were seen by portable
OCT during examination with the patient under
anesthesia (Fig. 3). Rather than the foveal convexity
and central cyst typically observed in typical XLRS,
OCT of the right eye showed an abnormally deep fo-
veal depression with termination of cyst walls at the
vertical midline of the fovea, consistent with resolved
MH and resolution of severe macular and peripheral
retinoschisis (Figs. 2b and 3) [5]. Partial vitreous sep-
aration accompanied peripheral schisis resolution. The
boy’s visual acuity at his last visit was measured as 20/
150 in the right eye using the LEA Symbols Test and
no light perception on the left, which had undergone
surgery. At the boy’s last follow-up visit, reduced com-
pliance with topical dorzolamide 2 % had resulted in
increased macular schisis, so the medication will be
continued indefinitely to prevent schisis-related ana-
tomic and visual complications.
Discussion
XLRS, first described in 1898, is one of the more fre-
quently encountered inherited macular retinal disorders
affecting young males [6]. Histologic studies have shown a
split and/or schisis within the superficial retinal layers, the
inner limiting membrane, the nerve fiber layer, and the
ganglion cell layer. The ganglion cell layer was found to be
thinned, with marked degeneration of photoreceptors as-
sociated with thinning of the inner nuclear layer [2].
Vitreous hemorrhages and RD, which remain major com-
plications, can occur at any age. Full-thickness MHs have
rarely been reported [7]. As RD becomes chronic, the retina
becomes transparent and corrugations flatten, mimicking
the appearance of retinoschisis. Although the presence of
large outer retinal holes or demarcation lines, ultrasono-
graphic characteristics, and response to laser photocoagula-
tion may facilitate distinguishing between RD and
retinoschisis, these features are not universal or conclusive,
especially in eyes with XLRS. We assert that spectral do-
main optical coherence tomography (SD-OCT) is invalu-
able in making this distinction. The raster scan should
include the margin of the retinal elevation to show whether
the outer retina is separated from the RPE. Unfortunately,
we could not perform imaging in the office with a conven-
tional upright SD-OCT unit using the “flying baby” tech-
nique, and our facility did not have access to a portable SD-
OCT unit at the time of initial presentation.
Retinoschisin protein has been identified throughout all
neuroretinal layers and is believed to function in cell adhe-
sion in the development and maintenance of retinal archi-
tecture, although the specific molecular interactions remain
unclear [8]. However, it is unclear whether the role of reti-
noschisin is purely structural or has functional implications
in fluid transport across the retina and RPE [8].
Carbonic anhydrase, one of the most ubiquitous enzyme
systems in the body, is also found in the red-green cones,
within the Mueller cells of the retina, and in the retinal pig-
ment epithelium. CAIs have been used in ophthalmology
for many years to reduce intraocular pressure. Recently,
their use has been expanded to treatment of cystoid macu-
lar edema and schisis in patients with several retinal dis-
eases, such as retinitis pigmentosa and uveitis [9]. CAIs are
thought to control and adjust the extracellular pH gradients
produced by the metabolic activity of cells. The administra-
tion of CAIs has been shown to enhance the fluid trans-
porter present in the RPE barrier, as well as to improve
retinal adhesiveness [10]. Improving the effectiveness of the
RPE pump in eyes with XLRS has been demonstrated clin-
ically to significantly reduce macular schisis and modestly
reduce midperipheral retinoschisis [4, 11]. However, the re-
duction in schisis in our patient receiving topical dorzola-
mide 2 % was dramatic. Schisis cavities may fluctuate
significantly in XLRS, but the degree of resolution in our
patient is unprecedented.
Fig. 1 Fundus photograph of the left eye showing total retinal
detachment with extensive proliferative vitreoretinopathy after
multiple surgeries
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The early onset of bullous schisis cavities in our pa-
tient was an indication of early and severe vitreous de-
generation (syneresis). Intraoperatively, the posterior
hyaloid face of the operative eye was surprisingly easy to
lift off the macula, although it was more tightly adherent
in areas of bullous schisis, which resulted in enlargement
of inner retinal holes and required excision of the schisis
cavities. This may suggest a differential expression of the
functional defect associated with RS1 mutation. We pre-
viously reported a complicated course when repairing
RD in another infant with severely bullous XLRS due to
an inability to separate the posterior hyaloid face from
the most bullous portions of peripheral retinoschisis
[12]. The vitreous remnant became a scaffold for PVR,
which led to multiple recurrences of RD. Another report
in the literature describes the use of combined external
drainage and vitrectomy for severe XLRS; however, that
also can cause outer retinal holes, increasing risk of PVR
[13]. In the nonsurgical eye, it is unclear whether the
partial vitreous separation was spontaneous or the result
of retraction of the inner retina from schisis reduction
following dorzolamide [14]. If the vitreous separation
was important in schisis reduction, intravitreal autolo-
gous plasmin or ocriplasmin could be beneficial to either
obviate vitrectomy or reduce the vitreoretinal scaffold
for PVR formation in these complex eyes.
Conclusions
This case report highlights several points. XLRS should al-
ways be included in the differential diagnosis for bilateral
poor visual behavior in an infant boy. Severe peripheral
bullous retinoschisis may create posterior corrugations
that mimic rhegmatogenous RD. Clinical suspicion for RD
in infants with XLRS should be confirmed preoperatively
by OCT. Although vitreous separation plays an important
role in resolution of peripheral bullous retinoschisis, top-
ical dorzolamide may facilitate resolution of both severe
macular and peripheral schisis.
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Fig. 2 Fundus photographs of the patient’s right eye. a Posterior corrugation and cystic fovea appearing like retinal detachment before
treatment. b Regression of macular and peripheral schisis cavities following topical dorzolamide with residual intraschisis hemorrhage
Fig. 3 Optical coherence tomographic image of the patient’s right
eye after treatment with dorzolamide, showing termination of cyst
walls with deep foveal depression
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